Review of Management of Gastrointestinal Stromal Tumor in Low-Resource Centers


  •   Seke Manase Ephraim Kazuma

  •   Bright Chirengendure

  •   Patrick Musonda

  •   Joseph Musowoya

  •   Royd Ngoma

  •   Boniface Kaela

  •   Simunyama Luyando

  •   Kamwi Mundia


Gastrointestinal stromal tumors (GIST) account for 1% to 3% of gastrointestinal tract tumors and are the most common of the mesenchymal tumors. Carcinogenesis of GIST arises in the interstitial cells of Cajal (ICC) and in the myenteric plexus of the gastrointestinal tract due to a mutation of the kinase receptor (KIT, also known as CD117) and the platelet-derived growth factor A (PDGFA) gene leading to activation of the tyrosine kinase receptor. The exact incidence and prevalence of GIST is not known. Symptoms of GIST are non-specific; they present with GI bleeding due to ulceration (50%), abdominal pain (20% to 50%), dysphagia (esophageal GIST) and GI obstruction (10% to 30%) (7,10). Signs include abdominal mass and fullness. A computerized tomographic (CT) scan is the preferred imaging to evaluate GIST. Diagnosis is confirmed by immunohistochemical (IHC) staining a of biopsy sample for medical treatment tyrosine kinase inhibitors (TKI). Surgical resection with negative microscopic margins is the gold standard treatment of GIST. TKI are required for tumor reduction to increase chances of respectability (neoadjuvant therapy) or to prevent recurrence and reduce the progression of advanced, resectable GIST.

Keywords: CD117, GIST, gastrointestinal stromal tumor, KIT, TKI


Bischof DA, Kim Y, Blazer DG, Behman R, Karanicolas PJ, Law CH, et al. Surgical management of advanced gastrointestinal stromal tumors: An international multi-institutional analysis of 158 patients. Journal of the American College Surgeons. 2014; 219: 439-449.

Lamba G, Gupta R, Lee B, Ambrale S, Liu D. Current management and prognostic features for gastrointestinal stromal tumor (GIST). Experimental Hematology and Oncology. 2012; 1(1): 14.

Boşoteanu M, Boşoteanu C, Deacu M, Aşchie M. Differential diagnosis of a gastric stromal tumor: case report and literature review. Romanian Journal of Morphology and Embryology. 2011; 52(4): 1361–1368.

Michael S, Emmanouel D, Charikleia S, Panagiotis S, Electra P, Georgia L, et al. Gastrointestinal stromal tumor. World Journal of Surgical Oncology. 2009; 7: 61.

Liu P, Tan F, Liu H, Ge J, Liu S, Lei T, et al. Skin metastasis of gastrointestinal stromal tumors: a case series and literature review. Cancer Management and Research. 2020; 12: 7681.

Yasemin A, Mehmet B. Gastrointestinal stromal tumor: diagnosis and management. Internation Journal of Surgery Research Practice. 2019; 6: 93

El-Menyar A, Mekkodathil A, Al-Thani H. Diagnosis and management of gastrointestinal stromal tumors: an up-to-date literature review. Journal of Cancer Research Therapeutics. 2017; 13(6): 889–900.

Popivanov G, Tabakov M, Mantese G, Cirocchi R, Piccinini I, D’Andrea V, et al. Surgical treatment of gastrointestinal stromal tumors of the duodenum: a literature review. Translational Gastroenterology and Hepatology, 2018; 3.

Flores-Funes D, Lirón-Ruiz RJ, Pérez-Guarinos CV, Martín-Lorenzo JG, Torralba-Martínez JA, Giménez-Bascuñana A, et al. Clinical and pathological features of gastrointestinal stromal tumors (GIST) in a single institution: a descriptive study and review of the literature. Cirugía Española (English Edition), 2017; 95(7): 391-396.

Marcella C, Shi RH, Sarwar S. Clinical overview of GIST and its latest management by endoscopic resection in upper GI: a literature review. Gastroenterology Research and Practice. 2018; 2018: 6864256.

Yang J, Yan J, Zeng M, Wan W, Liu T, Xiao JR. Bone metastases of gastrointestinal stromal tumor: a review of published literature. Cancer Management and Research. 2020; 12: 1411–1417.

Rodrigues JBSR, Campanati RG, Nolasco F, Bernardes AM, Sanches SR, Savassi-Rocha PR. Pre-operative gastric gist downsizing: the importance of neoadjuvant therapy. Archive of "Arquivos Brasileiros de Cirurgia Digestiva: ABCD". 2019; 32(1): 10–12.

Kale SS, Sachdev MS, Ismail MK, Davila R, Tombazzi CR. A case and literature review of complicated gastrointestinal stromal tumors. Gastroenterol Hepatology. 2008; 4(9): 650–657.

Madhavan A, Phillips AW, Donohoe CL, Willows RJ, Immanuel A, Verril M, et al. Surgical management of gastric gastrointestinal stromal tumours: comparison of outcomes for local and radical resection. Gastroenterology Research and Practice. 2018; 2018.

Đokić M, Novak J, Petrič M, Ranković B, Štabuc M, Trotovšek B. Case report and literature review: patient with gastroduodenal intussusception due to the gastrointestinal stromal tumor of the lesser curvature of the gastric body. BMC Surgery. 2019; 19(1): 1-6.

Prablek M, Srinivasan VM, Srivatsan A, Holdener S, Oneissi M, Heck KA, et al. Gastrointestinal stromal tumor with intracranial metastasis: case presentation and systematic review of literature. BMC Cancer. 2019; 19(1): 1-7.

Shah K, Chan KKW, Ko YJ. A systematic review and network meta-analysis of post-imatinib therapy in advanced gastrointestinal stromal tumour. Current Oncology. 2017; 24(6): e531-e539.

Antonioli DA. Gastrointestinal autonomic nerve tumors. Expanding the spectrum of gastrointestinal stromal tumors. Archives of Pathology and Laboratory Medicine. 1989; 113(8): 831-833.

Appelman HD. Smooth muscle tumors of the gastrointestinal tract. What we know now that Stout didn’t know. American Journal of Pathology. 1986; 10: 83–99.

Franquemont DW. Differentiation and risk assessment of gastrointestinal stromal tumours. American Journal of Pathology. 1995;(103):41–47.

Mazur MT, Clark HB. Gastric stromal tumors. Reappraisal of histogenesis. American Journal of Surgical Pathology. 1983; 7(6): 507-519.

Miettinen M, Virolainen M. Gastrointestinal stromal tumors--value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas. American Journal of Surgical Pathology. 1995; 19(2): 207-216.

Mikhael AI, Bacchi CE, Zarbo RJ, Ma CK, Gown AM. Cd34 expression in stromal tumors of the gastrointestinal-tract. Applied Immunohistochemistry, 1994; 89-93.

Corless CL, Fletcher JA, Heinrich MC. Biology of gastrointestinal stromal tumors. Journal of Clinical Oncology. 2004; 22(18): 3813–3825.

Subramanyam B, Pond SM, Eyles DW, Whiteford HA. Fouda Stroke Therapy Academic Industry Roundtable (STAIR): Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke. 1999; 30(12): 2752-2758.

Heinrich MC, Corless CL, Duensing A, McGreevey L, Chen CJ, Joseph N, et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science. 2003; 299(5607): 708-710.

Agaram NP, Wong GC, Guo T, Maki RG, Singer S, DeMatteo RP, et al. Novel V600E BRAF mutations in imatinib‐naive and imatinib‐resistant gastrointestinal stromal tumors. Genes, Chromosomes and Cancer. 2008; 47(10): 853-859.

Ahmed M. Recent advances in the management of gastrointestinal stromal tumor. World Journal of Clinical Cases. 2020; 8(15): 3142-3155.

Beham AW, Schaefer IM, Schüler P, Cameron S, Ghadimi BM. Gastrointestinal stromal tumors. International Journal of Colorectal Disease. 2012; 27(6): 689–700.

Carney JA, Sheps SG, Go VL, Gordon H. The triad of gastric leiomyosarcoma, functioning extra-adrenal paraganglioma and pulmonary chondroma. New England Journal of Medicine 1977; 296(26): 1517-1518.

Nishida T, Blay JY, Hirota S, Kitagawa Y, Kang YK. The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines. Gastric Cancer. 2016; 19(1): 3-14.

Caterino S, Lorenzon L, Petrucciani N, Iannicelli E, Pilozzi E, Romiti A, et al. Gastrointestinal stromal tumors: correlation between symptoms at presentation, tumor location and prognostic factors in 47 consecutive patients. World Journal of Surgical Oncology. 2011; 9(1): 1-10.

Lim KT. Surgical treatment of gastrointestinal stromal tumors of the stomach: current status and future perspective. Translational Gastroenterology and Hepatology. 2017; 2: 104.

Gervaz P, Huber O, Morel P. Surgical management of gastrointestinal stromal tumours. British Journal of Surgery. 2009; 96(6): 567–578.

Tornillo L, Terracciano LM. An update on molecular genetics of gastrointestinal stromal tumours. Journal of Clinical Pathology. 2006; 59(6): 557–563.

DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Annals of Surgery. 2000; 231(1): 51-58.

Koo DH, Ryu MH, Kim KM, Yang HK, Sawaki A, Hirota S, et al. Asian consensus guidelines for the diagnosis and management of gastrointestinal stromal tumor. Cancer research and treatment: official journal of Korean Cancer Association, 2016; 48(4): 1155.

Coe TM, Fero KE, Fanta PT, Mallory RJ, Tang CM, et al. Population-based epidemiology and mortality of small malignant gastrointestinal stromal tumors in the USA. Journal of Gastrointestinal Surgery, 2016; 20(6): 1132-1140.


How to Cite
Kazuma, S. M. E., Chirengendure, B., Musonda, P., Musowoya, J., Ngoma, R., Kaela, B., Luyando, S., & Mundia, K. (2021). Review of Management of Gastrointestinal Stromal Tumor in Low-Resource Centers. European Journal of Clinical Medicine, 2(6), 5–9.